PhRMA To Announce Clinical Trial Registry Sept. 8
This article was originally published in The Pink Sheet Daily
Executive Summary
The Pharmaceutical Research & Manufacturers of America is expected to announce an industry-wide clinical trial registry plan Sept. 8
You may also be interested in...
Antidepressant Makers Expected To Testify At Sept. 9 Hearing On Trial Data Disclosure
House Commerce/Oversight Subcommittee Vice Chairman Greg Walden will oversee discussion of FDA, industry handling of data on antidepressant-related pediatric suicides.
GlaxoSmithKline Clinical Trial Registry Begins With Avandia
Company posts 64 study summaries for the diabetes drug on its new clinical trial registry. Avandia summaries offer first real-world example of how industry trial registries will work.
US FDA Alzheimer Guidance Update Reflects Changes In Biomarkers – And Leadership
Latest update to draft guidance on early Alzheimer’s drug development is the third iteration of a document first published in 2013. The history of the guidance is a reflection of structural and leadership changes in the neurology review team at FDA.